The State of the Phase I Market

Market size, growth estimates, and Service Quality and Loyalty profiles for major Phase I service providers

Report Content:

This report is divided into four sections:

1. Market Dynamics: Including the volume of Phase I studies and the volume of Phase I studies being outsourced, market size estimates for Phase I services and proportion of work that will be distributed amongst large global, mid-size multi-service, and specialty Phase I CROs, and how, if at all, sponsors see patient populations, multi-center studies, and other trends influencing study conduct in the future

2. Geographical Trends: Where the industry conducts its Phase I studies currently and how this geographic mix will be different in 2014

3. Service Provider Selection Criteria: The attributes that sponsors use to make their service provider selection decisions, which attributes are gaining in importance, and which providers are being solicited for Phase I work and being awarded that work

4. Service Provider Phase I Quality Ratings: Profiles of 16 Phase I service providers where we identify where specific providers miss, meet, and exceed their customers’ delivery quality expectation across 10 critical dimensions

As always, an appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study.

What Readers Will Learn:

  • Discover why access to patient populations and alternative geographies should figure into your strategic planning
  • Learn the tools sponsors use to select service providers and which providers best meet sponsors' service quality expectations
  • See how the proportion of Phase I outsourcing spend is divided amongst large, mid-size, and specialty Phase I providers

Sample Charts & Graphs:

report_chartsample_phase1market.png

 Other Measurements Reported:

  • Attributes measured for Service Quality
  • Attributes for Service Provider Selection
 

Similar Reports:

Purchasers of this report also purchased:

  • 2011 CRO Quality Benchmarking Study
  • The Voice of the Site Coordinator
  • The Future of Clinical Monitoring

Companies Profiled:

  • CEDRA
  • Cetero
  • Charles River
  • Covance
  • i3 Pharma Services
  • ICON
  • INC Research
  • Kendle
  • Medpace
  • PAREXEL
  • PharmaNet
  • PPD
  • PRA
  • Quintiles
  • SGS Life Sciences
  • West Coast Clinical Trials